Key facts
- WELLINGTON MANAGEMENT GROUP LLP filed SCHEDULE 13G/A for Blueprint Medicines Corporation Common Stock (BPMC).
- Disclosed ownership: 4.8%.
- Date of event: 31 Mar 2025.
WELLINGTON MANAGEMENT GROUP LLP - 31 Mar 2025 SCHEDULE 13G/A Report for Blueprint Medicines Corporation Common Stock (BPMC)
- Filing Manager
- WELLINGTON MANAGEMENT GROUP LLP
- Reporting Manager
- Wellington Management Group LLP
- Symbol
- BPMC
- Shares outstanding
- 64,027,208 shares
- Disclosed Ownership
- 3,073,306 shares
- Ownership
- 4.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 12 May 2025, 10:44:44 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Key filing fact
WELLINGTON MANAGEMENT GROUP LLP disclosed 4.8% ownership in Blueprint Medicines Corporation Common Stock (BPMC) on 31 Mar 2025.
Change
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 12 May 2025, 10:44.
Research use
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Reporting managers (3)
Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Wellington Management Group LLP | 4.8% | 3,073,306 | 0 | 2,785,754 | Taisia Lowe | Regulatory Analyst | |
| Wellington Group Holdings LLP | 4.8% | 3,073,306 | 0 | 2,785,754 | Taisia Lowe | Regulatory Analyst | |
| Wellington Investment Advisors Holdings LLP | 4.8% | 3,073,306 | 0 | 2,785,754 | Taisia Lowe | Regulatory Analyst |
CIK / CUSIP context first